Venture investors evaluating deep tech startups cannot rely on the metrics that made software investing scalable. In deep tech, deals often happen before a product is commercially viable, so revenue, customer acquisition cost and churn may not exist or may not be meaningful yet. Instead, diligence has to center on scientific validity, technical de-risking milestones and the defensibility of hard-to-reproduce intellectual property. The stakes of getting this shift wrong are measurable: Boston Consulting Group's research on deep tech investing finds these companies take an average of 25% to 40% more time to mature between each funding stage, from seed through Series D, than other tech investments.
The Core Differences in Due Diligence
Traditional software diligence leans on traction. An investor can read monthly recurring revenue, user growth and engagement, and unit economics to judge whether a business model is scaling. Deep tech inverts that sequence. MIT's REAP program, which studies the sector, characterizes deep tech ventures as those "positioned at the knowledge frontier with long and uncertain R&D cycles," built on scientific discoveries or engineering innovations around "unique, protected or hard-to-reproduce technological or scientific advantages."
That definition carries direct diligence consequences. Because the core asset is a scientific or engineering breakthrough rather than a deployed product, the first evaluation questions are about feasibility, not adoption. Practitioners writing on deep tech investing describe a blended toolkit: conventional venture metrics still matter eventually, but early-stage evaluation has to add scientific and engineering yardsticks. One framework some investors use is a "tech milestone per dollar" lens—asking, for each tranche of investment, how much the technology improves or de-risks. It is an imprecise measure, but it forces disciplined thinking about the efficiency of R&D spend before any revenue exists to anchor the analysis.
Risk Assessment: Technology vs. Market
The dominant risk also changes category. In software investing, the technology usually works; the open questions are whether customers adopt it, how competition unfolds, and whether the business model holds within a known technological paradigm. Deep tech flips that exposure toward the technology itself. The central uncertainties are whether the science is valid, whether the innovation can be engineered into a manufacturable, scalable product, and whether it can clear regulatory or technical milestones on the path to commercialization.
This is why deep tech diligence is described as balancing visionary potential with pragmatic scrutiny. An investor is not merely asking whether a market exists, but whether the underlying claim will survive experimentation, iteration and scale-up—processes that can take years before a viable product emerges. Many deep tech products also depend on advances in hardware, manufacturing processes or broader ecosystem adoption, which adds infrastructure risk that a SaaS company simply does not carry. Market risk does not disappear; it is simply downstream of a more fundamental technical question.
